AMBU B Ambu A/S Class B

AMBU FINANCIAL CALENDAR FOR 2023/24

AMBU FINANCIAL CALENDAR FOR 2023/24

This financial calendar lists the expected release dates of Ambu’s financial announcements for the financial year 2023/24, as well as the date of Ambu’s Annual General Meeting. 



2023

8 NOVEMBER 2023 Annual Report 2022/23
13 DECEMBER 2023 Annual General Meeting 2023



2024

30 JANUARY 2024 Earnings release Q1 2023/24
14 MAY 2024 Earnings release Q2 2023/24
30 AUGUST 2024 Earnings release Q3 2023/24
30 SEPTEMBER 2024 End of fiscal year 2023/24
5 NOVEMBER 2024 Annual Report 2023/24
4 DECEMBER 2024 Annual General Meeting 2024



The deadline for the inclusion of specific items on the agenda for the Annual General Meeting 2023 is 31 October 2023.





Ambu A/S

Baltorpbakken 13

2750 Ballerup

Denmark

Tel.

CVR no.: 63 64 49 19



CONTACT INFORMATION

Media

Tine Bjørn Schmidt

Head of Corporate Communications







Investors

Anders Hjort

Head of Investor Relations





ABOUT AMBU

Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia and patient monitoring solutions. Headquartered near Copenhagen in Denmark, Ambu employs around 4,500 people in Europe, North America, Latin America and Asia Pacific. For more information, please visit Ambu.com.

Attachment



EN
29/09/2023

Underlying

AMBU BAmbu A/S Class B

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ambu A/S Class B

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
AMBU B AMBU A/S CLASS B
5h / 30m 5h / 30m 1 EN
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
AMBU B AMBU A/S CLASS B
08/19/25 August 19, 2025 1 EN
Free Trial
AMBU B Ambu A/S Class ...

Ambu AS: 1 director

A director at Ambu AS bought 2,800 shares at 15.412USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

AMBU B AMBU A/S CLASS B
05/16/25 May 16, 2025 1 EN
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
AMBU B AMBU A/S CLASS B
05/08/25 May 8, 2025 1 EN
Jesper Ingildsen
  • Jesper Ingildsen
Free Trial
AMBU B Ambu A/S Class ...

Ambu (Buy, TP: DKK144.00) - Possibly isolated softness

Q2 was below our forecast, but the softness might be isolated to Q2 on what could be Chinese competitors dumping stock ahead of tariffs, which could become a tailwind. Notably, the 2024/25 guidance was maintained and includes headwinds from FX and tariffs. We reiterate our BUY, but have cut our target price to DKK144 (155).

AMBU B AMBU A/S CLASS B
05/07/25 May 7, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch